Surgical Robots Market Report Scope & Overview:

The Surgical Robots Market was valued at USD 11.33 Billion in 2025 and is expected to reach USD 38.27 Billion by 2035, growing at a CAGR of 12.95% from 2026 to 2035.

The Surgical Robots Market has spent the past two decades defined almost entirely by a single company, Intuitive Surgical's da Vinci platform effectively created the soft-tissue robotics category and held it with minimal competition for years. That era is genuinely ending now. Medtronic's Hugo and CMR Surgical's Versius have both cleared major U.S. regulatory hurdles within the past year, and a wave of smaller challengers, from Distalmotion to Johnson & Johnson's Ottava platform, are pursuing their own indications in parallel. Hospitals that once had one realistic vendor to negotiate with are suddenly facing genuine competitive choice, and that shift is reshaping pricing, service contracts, and adoption timelines across the industry.

In December 2025, FDA approved Medtronic plc's Hugo robotic-assisted surgery system for use in urologic surgical applications. This was considered to be one of the most important regulatory developments in the United States soft tissue robotics market.

To Get more information Surgical Robots Market - Request Free Sample Report

Surgical Robots Market Trends

• Multiple new FDA-cleared soft-tissue platforms are ending Intuitive Surgical's long-standing near-monopoly on robotic-assisted surgery.
• Ambulatory surgical centers are adopting robotic systems faster than hospitals as outpatient robotic procedures become more common.
• AI-assisted surgical planning and real-time imaging integration are becoming standard features on newer robotic platforms.
• Modular, multi-quadrant robot designs are gaining share for their flexibility across different surgical specialties.
• Financing rounds exceeding a hundred million dollars are becoming common among challenger surgical robotics companies scaling U.S. operations.

The U.S. Surgical Robots Market Outlook

The U.S. Surgical Robots Market was valued at USD 4.58 Billion in 2025 and is projected to reach USD 15.46 Billion by 2035, growing at a CAGR of 12.92% during 2026-2035.

The United States continues to dominate the global surgical robot industry, supported by its sophisticated healthcare infrastructure, widespread adoption of minimally invasive surgical methods, and significant ongoing investment in medical technology research. What has genuinely changed over the past year is competitive intensity, since Intuitive Surgical spent years as the default choice for hospitals building out robotic surgery programs, and newly cleared platforms from Medtronic and CMR Surgical are now giving hospital systems real vendor choice for the first time. Analysts covering the space have noted that while Intuitive's technology remains well ahead on maturity and surgeon familiarity, new entrants are expected to lengthen sales cycles as hospitals evaluate multiple systems rather than defaulting to a single vendor.

In December 2025, CMR Surgical Ltd. received 510(k) FDA clearance for its Versius Plus robotic system to perform gallbladder removal procedures, expanding the company's U.S. market entry beyond its initial indications.

Surgical Robots Market Segment Analysis

• By Application, orthopedics dominates the Surgical Robots Market with orthopedics holding 41.62% share in 2025 while neurology grows fastest registering a CAGR of 13.48% from 2026 to 2035.
• By End-Use, inpatient dominates the Surgical Robots Market with inpatient holding 63.85% share in 2025, while outpatient grows fastest, and outpatient registering a CAGR of 14.20% from 2026 to 2035.
• By Component, robotic systems dominate the Surgical Robots Market, with systems holding 52% share in 2025 while software & services grow fastest registering a CAGR of 15.60% from 2026 to 2035.

By Application, orthopedics dominates the surgical robots market while neurology grows fastest

Orthopedics holds 41.62% of the Surgical Robots Market, the largest single application, supported by the increasing volume of robot-assisted knee, hip, and spine procedures performed across hospitals and specialty surgical centers. Robotic assistance has become close to a standard offering for joint replacement surgery at leading orthopedic practices, since the precision these systems provide translates directly into measurably better implant alignment and patient outcomes.

Neurology is growing at a 13.48% CAGR, the fastest pace among applications, driven by advancements in minimally invasive neurosurgical techniques and growing demand for high-precision procedures in brain and spinal cord surgery. Improved imaging integration and navigation accuracy are opening up robotic assistance to increasingly delicate neurosurgical procedures that were considered too risky for robotic involvement just a few years ago.

By End-Use, inpatient dominates the surgical robots market while outpatient grows fastest

Inpatient settings account for 63.85% of end-use demand, the largest single category, owing to the high concentration of complex surgical procedures performed in hospital environments equipped with advanced robotic systems and the supporting staff to operate them. Complex, high-acuity procedures requiring extended recovery monitoring continue to anchor robotic surgery within traditional hospital settings.

Outpatient is the fastest-growing end-use setting, expanding at a 14.20% CAGR, as ambulatory surgical centers increasingly adopt robotic systems for procedures like joint replacements and hernia repairs that no longer require overnight hospital stays. Distalmotion's Dexter platform, cleared specifically for outpatient inguinal hernia repair, illustrates how newer robotic systems are being designed from the outset around outpatient workflows rather than adapted from hospital-focused platforms.

By Component, robotic systems dominate the surgical robots market while software & services grow fastest

Systems hold 52% of the market by component, the largest single category, since the physical robotic platform represents the foundational capital purchase that hospitals must make before any accessories, instruments, or software can be deployed. Established manufacturing and regulatory clearance processes around complete systems keep this component the anchor of vendor revenue and competitive positioning.

Software & Services is growing fastest, at a 15.60% CAGR, as AI-assisted surgical planning, procedure analytics, and ongoing technical support increasingly become recurring revenue streams that vendors build around their hardware platforms. Growing hospital reliance on data-driven surgical planning and outcome tracking is reinforcing this segment's above-average growth trajectory.

Regional Analysis

North America Surgical Robots Market Insights

North America commands the highest market share 47.50% in the Global Surgical Robots Market owing to advanced health care infrastructure, increasing use of minimally invasive surgical techniques, and heavy investments in R&D activities in the field of medicine. Increased competition between the platform providers following multiple approvals from the FDA will fuel growth within the market despite the aging adoption base.

The United States holds a major portion of the market (~85.00%) owing to the presence of top hospitals, leading medical device companies, and regulatory authorities that facilitate quick adoption of the product. Canada too makes a contribution to the market owing to its health care system and use of robotic surgery.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Surgical Robots Market Insights

Europe's surgical robots market is mature and steady, shaped by comprehensive national healthcare systems and strong regulatory frameworks that have supported robotic surgery adoption for years, including early European approval for platforms like Medtronic's Hugo well ahead of its U.S. clearance. Established hospital purchasing processes and growing government reimbursement support continue reinforcing steady demand across the region.

Germany tops Europe with a 25.80% market share due to its robust healthcare infrastructure and high level of medical technology production facilities. This is followed by France and the UK where demand depends on the well-developed healthcare infrastructure in each country and increasing reimbursement for robotic surgery procedures.

Asia Pacific Surgical Robots Market Insights

Asia Pacific is growing faster than any other region in this market, registering a CAGR of approximately 15.20% during 2026-2035, driven by expanding healthcare infrastructure investment, rising surgical procedure volumes, and growing government support for medical technology adoption across China and India. Rising middle-class access to advanced surgical care in markets where robotic surgery is still a relatively new capability is creating exactly the kind of first-time adoption growth that mature markets like North America can no longer generate.

China holds roughly 35.60% of the regional market, supported by its rapidly expanding hospital infrastructure and growing domestic robotic surgery manufacturing capability. India is developing rapidly with increased access to healthcare and rising number of operations; at the same time, Japan and South Korea are contributing to this process via their technologically advanced healthcare system.

Middle East & Africa and Latin America Surgical Robots Market Insights

The Middle East & Africa region is growing steadily as healthcare infrastructure investment expands across the Gulf states, supported by rising government spending on advanced medical technology and growing medical tourism industries. The rise in the region is the same, with Latin America rising due to Brazil's expanding healthcare market and increasing use of advanced surgery technology.

In the Middle East and Africa, the UAE holds the top position with a market share of 17.40%, mainly because of being a regional medical technology and healthcare hub. Brazil constitutes 26.60% of the Latin American market, mainly owing to its large healthcare market; Mexico contributes via its expanding private hospitals.

Market Dynamics

Growth Drivers: Minimally Invasive Surgery Demand and New Market Entrants Fueling Market Growth

Growing demand for minimally invasive treatments is the clearest driver behind this market's growth, as ongoing technological improvements in robotic-assisted systems and growing preference for precision-driven surgical results continue expanding robotic surgery's role across an increasingly wide range of procedures. The entry of well-capitalized new competitors, including Medtronic and CMR Surgical, is reinforcing this growth by expanding hospital access to robotic platforms and lowering the barrier to first-time adoption for systems that previously had only one realistic vendor.

Rising surgical patient populations, driven by aging demographics and growing chronic disease prevalence, are adding a meaningful additional demand line, as more patients require surgical intervention that increasingly defaults toward robotic assistance where available.

Restraints: High Capital Cost and Extended Sales Cycles Limiting Market Expansion

There is an inherent cost involved in robotic surgical systems that is not easy to justify in smaller hospitals and surgical facilities, especially in those markets where there are no proven methods of getting reimbursements for robotically assisted surgery procedures. The competition is increasing amongst the various providers of robotic solutions, which will prove good for the hospital in the future but is currently resulting in extended selling cycles.

Surgeon training and credentialing requirements add further complexity, since hospitals adopting a new robotic platform need to invest meaningfully in staff training before the system can be deployed at full clinical capacity.

Opportunities: Outpatient Platform Design and AI-Integrated Software Creating New Growth Avenues

Purpose-built outpatient robotic platforms represent a significant growth opportunity, as ambulatory surgical centers increasingly adopt robotic assistance for procedures that no longer require overnight hospital stays. Manufacturers who can design systems specifically around outpatient workflow efficiency, rather than adapting hospital-focused platforms, stand to capture meaningful share in this expanding application.

AI-integrated surgical planning and analytics software offers a second clear opportunity, as vendors increasingly build recurring software and services revenue around their hardware platforms rather than relying solely on system sales and instrument consumables.

Recent Developments:

• 2025: CMR Surgical Ltd. secured USD 200 million in financing to support its U.S. robotic surgery rollout, part of a broader wave of nine-figure funding rounds among challenger surgical robotics companies.
• 2025: Distalmotion SA's Dexter robotic system received de novo FDA clearance for outpatient inguinal hernia repair procedures, expanding the growing field of challenger platforms competing for U.S. market share.
• 2025: Johnson & Johnson MedTech completed its first U.S. clinical cases using its Ottava surgical robotics platform, including a gastric bypass procedure, ahead of a planned FDA submission.
• 2025: SS Innovations submitted a 510(k) application to the FDA seeking clearance for its SSi Mantra surgical robotic system, adding another entrant to the increasingly competitive U.S. soft-tissue robotics market.

Surgical Robots Market key players are:

• Intuitive Surgical, Inc.
• Medtronic plc
• Stryker Corporation
• Johnson & Johnson MedTech
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• CMR Surgical Ltd.
• Asensus Surgical, Inc.
• Renishaw plc
• THINK Surgical, Inc.
• Globus Medical, Inc.
• Accuray Incorporated
• Brainlab AG
• Vicarious Surgical Inc.
• Distalmotion SA
• Microbot Medical Inc.
• Siemens Healthineers AG
• B. Braun SE
• Karl Storz SE & Co. KG
• Meere Company Inc.

Surgical Robots Market Report Scope :